Emerald Mutual Fund Advisers Trust’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-335,661	Closed	-$3.14M	–	294
2016 Q4	$3.14M	Sell	335,661 -80,837	-19%	-$728K	0.15%	147
2016 Q3	$4.07M	Hold	416,498	–	–	0.21%	135
2016 Q2	$5.88M	Sell	416,498 -59,290	-12%	-$925K	0.33%	110
2016 Q1	$6.65M	Buy	475,788 +270,387	+132%	+$3.97M	0.37%	101
2015 Q4	$4.19M	Buy	+205,401	New	+$3.17M	0.22%	133

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's AGTC Position: Q1 2017 in Review

Emerald Mutual Fund Advisers Trust sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2017, closing a stake of 335,661 shares — an estimated $3.14M sold.

Emerald Mutual Fund Advisers Trust first reported a position in AGTC in Q4 2015 and held it in 5 quarters. The position peaked at $6.65M in Q1 2016. 89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

Emerald Mutual Fund Advisers Trust reported no remaining Applied Genetic Technologies Corporation position as of Q1 2017 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 335,661 Applied Genetic Technologies Corporation shares in Q1 2017, an estimated $3.14M.
Emerald Mutual Fund Advisers Trust first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 5 quarters.
Emerald Mutual Fund Advisers Trust's Applied Genetic Technologies Corporation position peaked at $6.65M in Q1 2016.
89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2017, filed 28 Apr 2017.